Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/24
End: 08/30/29
Due: 08/30/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS | NCT05829434 | Uwe Platzbecker | user2@example.com | None | 2024-03-31 | 2029-08-30 | 2030-08-30 | - | - | 2025-07-14 |